Brief: Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Ironshore Pharmaceuticals & Development, Inc. for JORNAY PM® for Canada and Latin America
09/05/2024 12:48
May 9 (Reuters) - Knight Therapeutics Inc GUD.TO :
* KNIGHT THERAPEUTICS ENTERS INTO EXCLUSIVE SUPPLY AND
DISTRIBUTION AGREEMENT WITH IRONSHORE PHARMACEUTICALS &
DEVELOPMENT, INC. FOR JORNAY PM® FOR CANADA AND LATIN AMERICA
* KNIGHT THERAPEUTICS INC: FINANCIAL TERMS OF AGREEMENT WERE
NOT
DISCLOSED
* KNIGHT THERAPEUTICS INC - FINANCIAL TERMS OF AGREEMENT
WERE NOT
DISCLOSED.
Source text for Eikon: ID:nGNX5XZtJm
Further company coverage: GUD.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Knight Therapeutics
See all newsBrief: Knight Therapeutics Announces Regulatory Approval Of Niktimvo In Brazil
Brief: Knight Therapeutics - Launches Tavalisse In Brazil For Chronic Immune Thrombocytopenia
Brief: Knight Therapeutics Enters Into Exclusive Distribution Agreement With Kyowa Kirin International For Poteligeo® (Mogamulizumab)
Brief: Knight Therapeutics Announces Regulatory Approval Of Tavalisse® In Colombia
Brief: Knight Therapeutics Announces Supplemental Regulatory Submission For Minjuvi In Brazil